Chronic inflammation in IBD is fueled by persistent dysbiosis, loss of barrier integrity, and immune hyperactivation, which trigger excessive cytokine release (IL-1β, IL-6, TNF-α) [32]. This evidence concerns the gene IL1B and inflammatory bowel disease.